EUVIMEDEUVIMED entdecken
Open Access

Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023

Navkirat Kahlon, Nahush Bansal, Sujatha Baddam, Jaisingh Rajput, Zaheer Qureshi

Oncotarget · 28.04.2026 · 17 (1) · 216-225

DOI: 10.18632/oncotarget.28877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 28.04.2026. Verfasst von Navkirat Kahlon und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Multiple Myeloma, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMolecular Targeted TherapyHumansSEER ProgramUnited StatesRetrospective StudiesCross-Sectional StudiesFemaleMaleMortality

Stichwörter der Autor:innen

SEER databaseepidemiologic trendsmortality reductionmultiple myelomatherapeutic advancements

Zitieren

APA

Kahlon, N., Bansal, N., Baddam, S., Rajput, J., & Qureshi, Z. (2026). Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023. Oncotarget, 17(1), 216-225. https://doi.org/10.18632/oncotarget.28877

Vancouver

Kahlon N, Bansal N, Baddam S, Rajput J, Qureshi Z. Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023. Oncotarget. 2026;17(1):216-225. doi:10.18632/oncotarget.28877

BibTeX
@article{Kahlon2026,
  author = {Kahlon, Navkirat and Bansal, Nahush and Baddam, Sujatha and Rajput, Jaisingh and Qureshi, Zaheer},
  title = {Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {216--225},
  doi = {10.18632/oncotarget.28877}
}
Kostenlos starten →